GOTHENBURG, Sweden, June 30, 2026 /PRNewswire/ — Oblique Therapeutics AB (“Oblique” or the “Company”) today announces the outcome of the rights issue that closed on June 30. The rights issue was …
Oblique Therapeutics AB Announces Outcome of Rights Issue of SEK 14.1 Million
Source: Finanznachrichten.de
Read Full Story →
